1. Home
  2. NSRX vs NA Comparison

NSRX vs NA Comparison

Compare NSRX & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$4.10

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

NA

Nano Labs Ltd

N/A

Current Price

$2.22

Market Cap

46.4M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NSRX
NA
Founded
2019
2019
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
46.4M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
NSRX
NA
Price
$4.10
$2.22
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$19.67
N/A
AVG Volume (30 Days)
12.3K
20.6K
Earning Date
03-25-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$1.58
52 Week High
$9.50
$6.10

Technical Indicators

Market Signals
Indicator
NSRX
NA
Relative Strength Index (RSI) 64.61 65.28
Support Level $2.90 $1.64
Resistance Level $4.49 $2.43
Average True Range (ATR) 0.28 0.14
MACD 0.04 0.03
Stochastic Oscillator 89.52 59.65

Price Performance

Historical Comparison
NSRX
NA

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: